University of Washington

University of Washington has been granted 691 US utility patents between 2015 and 2025, placing University of Washington at rank #647 across all assignees tracked by PlainPatent. This portfolio spans 169 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.1 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, University of Washington is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 65.3/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 432 grants, compared with 259 in the 2015–2019 window — a +67% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. University of Washington's 19.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark University of Washington against peers pursuing similar technology classes.